Catalyst4, Inc., 10% Owner at MapLight Therapeutics, Inc. (MLPT), bought 1,209,225 shares at $10.74 ($15.3M) on 2026-07-28, disclosed to the SEC on 2026-07-30.
Open-market purchase of $15.3M MLPT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.74 | 141,088 | $1.5M | 9.9% |
| 2 | $11.69 | 65,137 | $761K | 5.0% |
| 3 | $12.63 | 3,000 | $38K | 0.2% |
| 4 | $13.00 | 1,000,000 | $13.0M | 84.9% |
| Total | $12.66 avg | 1,209,225 | $15.3M | 100% |
| Filing → |